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Abstract
The matrix protein VP40 from Ebola virus plays an important role in the assembly process of virus particles by interacting with cellular
factors, cellular membranes, and the ribonuclearprotein particle complex. Here we show that the N-terminal domain of VP40 folds into a
mixture of two different oligomeric states in vitro, namely hexameric and octameric ringlike structures, as detected by gel filtration
chromatography, chemical cross-linking, and electron microscopy. Octamer formation depends largely on the interaction with nucleic acids,
which in turn confers in vitro SDS resistance. Refolding experiments with a nucleic acid free N-terminal domain preparation reveal a mostly
dimeric form of VP40, which is transformed into an SDS resistant octamer upon incubation with E. coli nucleic acids. In addition, we
demonstrate that the N-terminal domain of Marburg virus VP40 also folds into ringlike structures, similar to Ebola virus VP40. Interestingly,
Marburg virus VP40 rings reveal a high tendency to polymerize into rods composed of stacked rings. These results may suggest distinct
roles for different oligomeric forms of VP40 in the filovirus life cycle.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Ebola virus (EBOV) along with Marburg virus (MBV),
are members of a family of nonsegmented negative-strand
RNA viruses, the Filoviridae (Feldmann et al., 2001). The
mature particles have a tubular filamentous shape that can
be straight, circular, or branched with a uniform diameter of
80 nm (Ellis, 1987; Mavrakis et al., 2002). The RNA ge-
nome encodes seven structural proteins, including the ma-
trix protein VP40, which is positioned underneath the viral
membrane and ensures the integrity of the viral particle
(Geisbert and Jahrling, 1995). Viral matrix proteins are
multifunctional as they interact with cellular membranes
and viral components such as the ribonucleoprotein particle
(RNP) and most likely also the cytoplasmic tails of the
glycoproteins, in a process that triggers the formation and
the release of infectious particles from infected cells (Ga-
roff, Hewson, and Opstelten, 1998; Jin et al., 1997; Schmitt
et al., 2002; Waning et al., 2002; Zhang and Lamb, 1996).
Expression of VP40 in mammalian cells leads to the
production of virus-like particles, indicating that VP40 can
associate with and polymerize at membranes, which results
in the release of tubular structures (Jasenosky et al., 2001;
Timmins et al., 2001). The efficacy of release is thereby
strongly dependent on the presence of an intact late domain
at the N-terminus of VP40, which was reported to recruit
cellular factors (Harty et al., 2000; Martin-Serrano, Zang,
and Bieniasz, 2001). In addition, the formation of virus-like
particles is greatly enhanced upon coexpression of VP40
and the glycoprotein GP (Bavari et al., 2002; Noda et al.,
2002), which is recruited into lipid raft microdomains in a
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process that is similar to the assembly mechanisms of a
number of virus families (Manes et al., 2000; Manie et al.,
2000; Scheiffele et al., 1999; Zhang, Pekosz, and Lamb,
2000). Interestingly, these data reveal that VP40 contains
sufficient information for the formation of tubular structures
in vivo. MBV VP40 is also found at late endosomal mem-
branes and in inclusions containing assembled tubular nu-
cleocapsids in infected cells (Huang et al., 2002; Kolesni-
kova et al., 2000), in addition to its plasma membrane
localization at sites of viral budding (Kolesnikova et al.,
2000, 2002).
EBOV VP40 is a monomer in solution and is composed
of two domains (Dessen et al., 2000). The C-terminal do-
main is required for membrane association in vitro and in
vivo and its removal was shown to induce the formation of
ring-like structures by the N-terminal domain (Ruigrok et
al., 2000; Timmins et al., 2001). A similar ring formation is
observed when the VP40 interdomain interactions are de-
stabilized in vitro by mutagenesis or by urea treatment as
well as by binding of monomeric VP40 to liposomes (Sci-
animanico et al., 2000). Thus, a simple movement of the
C-terminal domain appears to allow the N-terminal domain
to form higher order oligomeric structures. Here we show
that EBOV VP40 can form two different oligomeric ring-
like structures that may function at distinct steps of assem-
bly and release. Similar rings are detected for MBV VP40,
which in addition polymerize into stacks.
Results
Oligomerization of EBOV VP40(1–212)
Purification of VP40 comprising residues 1 to 212
[VP40(1–212); Fig. 1 ] by gel filtration and its subsequent
analysis by chemical cross-linking and electron microscopy
show that it exists in two different oligomeric states in
solution (Fig. 2). VP40(1–212) elutes from a Superdex 200
gel-filtration column as two peaks at 11.4 ml and 12.5 ml
(Fig. 2a), both containing VP40(1–212) as judged by so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE). The first peak at 8.4 ml contains no detect-
able protein (data not shown). Chemical cross-linking
shows that the 11.4-ml peak can be cross-linked up to a final
species migrating as a broad band close to the 250-kDa
marker protein. The gel also shows the monomer band at 25
kDa as well as positions of intermediate forms, such as a
band at 50 kDa (the dimeric form), one above 75 kDa (most
likely a tetrameric form), and one close to 150 kDa (most
likely a hexameric form) (Fig. 2b). In contrast, the 12.5 ml
peak from the gel filtration experiment cross-links only to a
band migrating close to the 150-kDa marker protein as well
as the same intermediates as detected for the 11.4-ml peak
(Fig. 2b, lanes 7 and 8). Both peaks show a high content of
nucleic acid and the calculated OD280/260 ratios are 0.69
and 0.65, respectively. We subsequently treated VP40(1–
212) from the 12.5-ml peak with RNAse and/or DNAse to
get rid of nucleic acids; this, however, resulted in the im-
mediate precipitation of the protein, indicating that the
bound nucleic acids stabilize this oligomeric VP40(1–212)
form.
SDS–PAGE analysis further shows that VP40 eluting in
the 11.4-ml peak is partly SDS-resistant when separated
under SDS conditions without boiling the sample, which
results in a band migrating below the 250-kDa marker
protein (Fig. 2b; lane 2). In contrast, no SDS resistance is
observed for VP40(1–212) from the 12.5-ml peak (Fig. 2b,
lane 6). The cross-linking experiment of the sample derived
from the 12.5-ml peak also shows a faint band at approxi-
mately 250 kDa, which corresponds approximately to the
same size as detected in the 11.4-ml peak, as both gel
filtration peaks are not perfectly well separated and may
contain small amounts of the smaller or bigger form, re-
spectively. Subsequent analysis of samples from both peaks
by negative staining electron microscopy revealed ringlike
structures for both oligomeric states (Fig. 2c and e). Oligo-
meric VP40(1–212) from the 11.4-ml peak binds to the
carbon support film resulting in mostly top-view positions
(Fig. 2c), whereas samples from the 12.5-ml peak bind to
the carbon film in a way that mainly produces side views
and only a few top-view orientations (Fig. 2e). The top
views from the 11.4-ml peak (Fig. 2c) were then further
aligned against either three- or fourfold symmetry model
rings. These calculations reveal that approximately 65% of
the particles converge to fourfold symmetry and 35% to
threefold symmetry, suggesting that most of the particles in
this peak are octameric, which is also in agreement with the
cross-linking experiment. The presence of a minor popula-
tion with threefold symmetry is probably due to some cross
contamination between the 11.4- and 12.5-ml peaks (Fig.
2a), which is also evident in the cross-linking experiment.
We did not perform a complete single particle reconstruc-
tion from the images shown in Fig. 2c as they did not
Fig. 1. Schematic representation of EBOV and MBV matrix proteins VP40.
(a) EBOV VP40 contains two structurally related domains that are indi-
cated schematically. The two domains are shown as boxes based on the
crystal structure of VP40 (Dessen et al., 2000). Two constructs of EBOV
VP40, His-tagged VP40(1–212) and VP40(31–212) were expressed and
characterized. (b) Based on the amino acid sequence alignment MBV VP40
is also predicted to contain two domains. The N-terminal domain of MBV
VP40 (residues 1 to 186) was expressed as an MBP fusion protein.
360 J. Timmins et al. / Virology 312 (2003) 359–368
Fig. 2. Analysis of two oligomeric states of VP40(1–212). (a) Gel filtration chromatography of EBOV VP40(1–212) in which three peaks can be separated. The
OD280 and OD260 are shown as full and dashed lines, respectively. The volumes of elution are indicated. (b) Chemical cross-linking and SDS resistance of
VP40(1–212) from the 11.44 ml peak (lanes 1–4) and from the 12.56 ml peak (lanes 5–8). Lanes 1 and 5 correspond to the boiled samples, whereas lanes 2 and
6 correspond to the non- boiled samples. In lanes 3 and 7 the protein was treated with 0.1 mM EGS and in lanes 4 and 8, with 5 mM EGS. (c) Negative staining
electron microscopy images of samples derived from the 11.44 ml peak and (e) samples derived from the 12.56 ml peak, showing either rings in mostly top view
orientations (circles) in c or side view orientations (squares) in e. Symmetry analysis of selected images in top view orientations from panel c results mostly in
particles exhibiting fourfold symmetry (65%) and a minor fraction showing threefold symmetry (35%) (d). Single particle reconstruction of side views selected from
e gives rise to hexameric ring-like structures (f) as determined previously (Ruigrok et al., 2000; Scianimanico et al., 2000; Timmins et al., 2003).
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contain sufficient side views. In contrast, the side-view
images obtained from the 12.5-ml peak (Fig. 2e, white
squares) were used for single-particle analysis and 3D re-
construction. This resulted in a hexameric ringlike structure
(Fig. 2f) with the same shape and dimensions as those
determined before for ring-like VP40(31–212) and
VP40(31–319) (Ruigrok et al., 2000; Scianimanico et al.,
2000).
Oligomerization of nucleic acid free VP40(31–212)
To analyze the role of nucleic acid binding to VP40, we
purified the previously characterized fragment VP40(31–
212) (Ruigrok et al., 2000) under denaturing 8 M urea
conditions. The resulting denatured nucleic acid free form
of VP40(31–212) was then refolded in vitro by dilution and
separated on gel filtration. This resulted in a void volume
peak containing aggregated VP40(31–212) and a peak at 14
ml containing VP40(31–212) (data not shown). OD mea-
surements show that the 14 ml peak does not contain nucleic
acid (OD280/260 ratio of 1.68). Chemical cross-linking of
the 14-ml peak reveals the appearance of a second band
corresponding to a dimeric form (Fig. 3; lane 2), which is
also consistent with the elution position of a 40-kDa gel
filtration marker protein (MBP elutes at 14.5 ml; data not
shown). In order to determine whether the dimeric form of
VP40 can be transformed into a ring-like structure upon
addition of nucleic acids, we incubated nucleic acid free
dimeric VP40(31–212) with Escherichia coli nucleic acids
and analyzed it by SDS–PAGE. This shows that dimeric
VP40(31–212) is now transformed into a partly SDS-resis-
tant form migrating close to the 150-kDa marker protein
under nonboiling conditions and can be cross-linked to a
major species migrating above the 150-kDa marker protein
and minor fractions still corresponding to the dimeric form
as well as a band migrating close to the 100-kDa marker
protein (Fig. 3, lanes 3 and 4). Subsequent EM analysis
confirmed the formation of ring-like structures (data not
shown). This suggests that nucleic acid binding induces the
formation of ring-like structures from dimeric VP40 build-
ing blocks.
Oligomerization of MBV VP40
In order to analyze whether Marburg (MBV) VP40,
which shows only 29% sequence similarity to EBOV VP40,
can also form ring-like structures in solution, we expressed
MBV VP40 residues 1 to 186 as MBP fusion protein, which
corresponds to the N-terminal domain based on the crystal
structure of EBOV VP40 (Fig. 1b) (Dessen et al., 2000).
MBV VP40(1–186) was purified to homogeneity (Fig. 4a)
and analyzed by gel filtration chromatography, which indi-
cated an oligomeric form eluting from the column with an
estimated molecular weight comparable to a 600-kDa
marker protein (Superdex 200 elution volume 9 ml). After
removal of the MBP moiety by proteolytic cleavage, further
purification by gel filtration chromatography revealed that
MBV-VP40(1–186) “aggregates” and elutes in the void
volume (data not shown), while it migrates as a 24 kDa band
under reducing SDS–PAGE conditions (Fig. 4a, lane 2).
Analysis by negative staining electron microscopy shows
that MBV VP40(1–186) forms ringlike structures as an
MBP fusion protein (Fig. 4b) similar to the rings detected
for C-terminal truncated EBOV VP40 (Ruigrok et al.,
2000). The rings have an approximate outer diameter of
100 Å (3.5 Å) and are more irregular compared to the
images obtained for EBOV VP40(31–212), which may be
attributed to the flexibly linked MBP moiety at the N-
terminus. In addition, after proteolytic removal of the MBP
moiety, the remaining ring structure polymerizes into rods
composed of stacked rings (Fig. 4c). This tendency of MBV
VP40(1–186) to polymerize makes it also impossible to
determine the exact oligomeric state. Furthermore, the
MBV VP40(1–186) preparations analyzed are most likely
free of nucleic acids as indicated by the measured OD280/
260 ratio (1.7).
Discussion
Viral matrix proteins are characterized by their ability to
interact with cellular membranes and to self-assemble into
higher order structures in order to exert their fundamental
role in viral assembly and budding. Matrix proteins from
members of the Mononegavirales have previously been
shown to polymerize both in vitro (Gaudin et al., 1997;
Heggeness, Smith, and Choppin, 1982; McCreedy, McKin-
non, and Lyles, 1990) and in vivo with the observation of
Fig. 3. Analysis of refolded nucleic acid free VP40(31–212) reveals a
stable dimer. Refolded VP40(31–212) (lane 1) was chemically cross-linked
with 5 mM EGS, which gives rise to a second band migrating between the
37- and 50-kDa marker proteins (lane 2). Incubation of dimeric VP40 with
E. coli nucleic acids results in a new SDS resistant form of VP40(31–212)
migrating close to the 150 kDa marker protein when loaded onto the SDS
PAGE without prior boiling of the sample (lane 3). Chemical cross linking
of VP40(31–212) incubated with E. coli nucleic acids, with EGS (5 mM)
results in a high-molecular-weight band migrating above the 150-kDa
marker protein (lane 4). Note that some protein remains dimeric and a
small fraction migrates close to the 100-kDa marker protein (marked by
asterisks). The samples were separated on a 5–15% gradient gel and bands
were detected by Coomassie blue staining.
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crystalline lattices on the plasma membrane (Buechi and
Bachi, 1982). Notably, the M protein of vesicular stomatitis
virus (VSV) can be found either in monomeric or polymeric
form in solution, depending on the salt concentration (Gau-
din et al., 1995, 1997). This tendency to polymerize in vitro
has been proposed to reflect an ability to self-assemble in
vivo to form a protein scaffold required for viral assembly
(Gaudin et al., 1997). However, in addition to the filovirus
matrix protein VP40, only Borna disease virus matrix pro-
tein M was shown to adopt a specific oligomeric structure in
solution implying functional similarities (Kraus et al.,
2002), whereas all other matrix proteins from Mononega-
virales exhibit only polymerization properties.
Here we show that the matrix protein VP40 from EBOV
can adopt at least four conformational states, a monomeric
form (Dessen et al., 2000), a dimeric form, as well as two
higher order oligomeric ring-like structures. Efficient sepa-
ration of both oligomeric forms was achieved for VP40(1–
212), whose oligomeric states can be interpreted as hexa-
mers and octamers, based on the following observations.
1. We recently solved the crystal structure of octameric
VP40 composed of the N-terminal residues 31 to 212 in
complex with a sequence-specific ssRNA segment. The
structure reveals that only the mode of RNA binding allows
octamerization and stabilizes the otherwise weak protein–
protein interface of the dimer–dimer interaction in the oc-
tamer (Gomis-Rueth et al., 2003). VP40(31–212) present in
the crystal is completely SDS-resistant when separated un-
der nonboiling conditions (see Fig. 5a in Gomis-Ru¨th et al.,
2003), indicating that the observed SDS resistance of
VP40(1–212) in the 11.4-ml peak corresponds to the oc-
tameric form stabilized by the presence of nucleic acids.
Further indication of the presence of octamers comes from
EM analysis. VP40(1–212) from the 11.4-ml peak associ-
ates with the carbon film preferentially with a top-view
orientation. Analysis of the symmetry of these top-view
images indicates clearly that most of the images converge to
fourfold symmetry. The presence of a minor fraction exhib-
iting threefold symmetry may result from the poor separa-
tion of both peaks at 11.4 and 12.5 ml. The images obtained
from the 11.4-ml peak of VP40(1–212) did not contain
enough side views to calculate a complete single-particle
reconstruction. In summary, these features indicate that the
11.4-ml peak contains mostly octameric forms of VP40(1–
212).
The discrepancy between the migration behavior of the
SDS-resistant form and the final cross-linked species of
VP40(1–212) on SDS–PAGE might be due to the chemical
cross-linking reactions in the presence of nucleic acids. The
VP40 construct [VP40(31–212)] used for crystallization
showed the same behavior on SDS–PAGE, that is, the final
cross-linked product migrated much slower than the SDS-
resistant form (W.W., unpublished data, and Gomis-Ru¨th et
al., 2003), indicating that it represents the same octameric
oligomeric state that can be crystallized.
2. We have described previously that VP40(31–212) and
Fig. 4. Polymerization of MBV VP40. (a) SDS–PAGE analysis of MBV
VP40. (Lane 1) MBP-MBV-VP40(1–186). (Lane 2) MBV-VP40(1–
186) after the removal of the MBP moiety. (b) Electron micrographs of
MBV-VP40(1–186) fused to MBP and (c) MBV-VP40 (1–186) after
removal of the MBP. In b, single rings are circled and stacks containing
two to three ringlike structures are pointed out by arrows. A few top
views are circled in c. Stacking of the rings creates a striation pattern
with a spacing of 42 Å (3.5 Å).
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VP40(31–326) or VP40(31–139) can form hexamers based
on electron microscopy single-particle reconstruction re-
sults (Ruigrok et al., 2000; Scianimanico et al., 2000).
Chemical cross-linking of VP40(1–212) from the 12.5-ml
peak indicates a second oligomeric form different and
smaller than the octameric form as its final cross-linked
species migrates close to the 150-kDa marker protein and
shows no SDS resistance. The analysis of VP40(1–212)
from the 12.5-ml peak by EM shows that this form prefers
to bind to the carbon support film in a side-on-view position.
These side views were then selected for single-particle anal-
ysis and 3D reconstruction, which resulted in a hexameric
ring-like structure as determined previously for VP40(31–
212) and VP40(31–319) (Ruigrok et al., 2000; Scianima-
nico et al., 2000), indicating that the 12.5-ml peak contains
mostly hexamers. In addition, some cross contamination
with octamers can be observed as the chemical cross-linking
experiment also shows a faint band above the 250-kDa
marker protein at the same position as the octameric cross-
linked form of VP40(1–212).
As we selected only side views for the calculations of our
previous single particle reconstruction images, it is possible
that we have been largely biased toward the hexameric form
in previous experiments and we cannot exclude that these
samples may have contained mixtures of hexamers and
octamers (Ruigrok et al., 2000; Scianimanico et al., 2000).
Although we generally tried to get rid of all nucleic acids
during purification using different protocols we did not
succeed for either oligomeric form. Notably, RNAse and
DNAse treatment of VP40(1–212) present in the 12.5-ml
peak led to immediate precipitation, indicating that the
nucleic acids may stabilize this oligmeric form and thus
keep it in solution. Therefore, our attempts to analyze both
oligomeric VP40(1–212) samples either by native mass
spectroscopy or analytical ultracentrifugation to confirm the
conclusions on the oligomeric states did not produce con-
clusive results due to the presence of heterogeneous
amounts of nucleic acids in the samples (data not shown).
Purification of VP40(31–212) under denaturing condi-
tions and subsequent refolding resulted in a stable dimeric
form that can be converted into an SDS-resistant octamer
upon incubation with E. coli nucleic acids. The relevance of
this conversion is further demonstrated by the fact that
recombinant full-length VP40(1–326) can be converted into
a high-molecular-weight SDS-resistant form upon incuba-
tion with E. coli nucleic acids and the same SDS-resistant
form of wild-type VP40 is found in Ebola-virus-infected
cells (see Fig. 5b in Gomis-Ru¨th et al., 2003), thus strongly
indicating a physiological role for RNA bound octameric
VP40 in the life cycle of the virus.
The question, however, remains why the refolding ex-
periment in the absence of nucleic acids did not clearly
produce hexamers, too. One reason could be the absence of
N-terminal residues 1 to 30 in VP40(31–212), which may be
required for efficient hexamer formation. The other reason
could be that nucleic acids also stabilize the hexameric form
albeit in a different manner than the octameric form. Note
that the 12.5-ml peak shown in Fig. 2b also contains nucleic
acids. The presence of a lower molecular weight band (100
kDa) in the cross-linking experiment shown in Fig. 3, might
also indicate the generation of hexamers upon incubation of
dimers with nucleic acids.
Specific and unspecific nucleic acid binding of octameric
VP40 is also evident from the octamer structure. A grasp
surface representation of the electrostatic potential shows
that the pore of the ring carries a strong basic charge, which
is not completely involved in specific binding of ssRNA.
Notably residues Lys 127 (not conserved between MBV and
EBO VP40) and Arg 148 (conserved) contribute to the
overall charge besides the exposed residues directly in-
volved in specific ssRNA binding (Fig. 5). It is conceivable
that the central pore of the hexamer carries a similar strong
basic charge if the hexamer is composed of the same
dimeric unit as the octamer (Gomis-Ru¨th et al., 2003) as
suggested in the model below (Fig. 6). Therefore nucleic
acid binding in the central pore could also stabilize a hex-
amer ring structure.
Sequence alignment of EBOV (Zaire strain) and MBV
(Popp strain) VP40 reveals a similarity of 29% (Bukreyev et
al., 1993) and the conservation of the primary sequence is
most prominent in the regions of the N-terminal domain
(Dessen et al., 2000), which mediates oligomerization. The
higher sequence conservation in this region may be due to
Fig. 5. Electrostatic potential map of octameric VP40 with RNA. The
central pore of the octamer carries a basic charge, which is also the binding
site for the triribonucleotide, shown as an all atom model. Some basic
residues not involved in ssRNA binding are labeled. Note that the most
prominent basic residue in the pore is Lys 127, which is not conserved
between EBO and MBV VP40, indicating potential differences in unspe-
cific nucleic acid interaction. Regions of electrostatic potential less than 21
KBT are shown in red and regions less than 21 KBT are shown in blue
(KB, Boltzmann constant; T, absolute temperature). The figure has been
generated with the program GRASP (Nicholls et al., 1991).
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the dual structural role of the N-terminal domain in the mono-
meric form and in the oligomeric forms as described here. We
also show here that truncated MBV VP40 can form similar
ring-like structures that tend to polymerize into rods composed
of stacked rings. OD (280/260) measurements indicate that
oligomeric MBV VP40 is free of nucleic acids. However, its
polymerization tendency did not allow distinguishing bio-
chemically or by mass spectroscopy whether MBV VP40(1–
186) forms also mixtures of oligomeric states.
The polymerization of MBV VP40 results in a striation
with a repeat of 42 Å ( 3.5 Å). Comparison of this
pattern of striation with images of fixed and negatively
stained MBV particles reveals that virus particles contain a
similar striation pattern, which was postulated to be posi-
tioned underneath the membrane, while connecting to the
RNP complex (Mavrakis et al., 2002). These observed
structural similarities raise the possibility that these ring
structures are involved in virus assembly as suggested pre-
viously (Ruigrok et al., 2000; Scianimanico et al., 2000).
In summary, our data indicate that dimeric VP40 may be
the building block of any higher molecular weight oligomer.
We therefore suggest the following two models for oligo-
meric ringlike VP40 structures. (a) For both oligomeric
forms, the C-terminal domain, which interacts with the
N-terminal domain in the metastable monomeric conforma-
tion (Dessen et al., 2000; Scianimanico et al., 2000), has to
move to allow dimer formation (Fig. 6a). This will also lead
to the flexible linkage of the C-terminal domain to the ring
structures (Fig. 6). (b) In the hexameric form, the dimer–
dimer interface might be stabilized by the N-terminal region
of VP40 most notably residues 31 to 68 and the interface
might be further stabilized by N-terminal residues 1 to 30,
whose presence allows efficient separation of both oligo-
meric forms. (c) In contrast, the same region (at least resi-
dues 31 to 68) is disordered in the octameric crystal struc-
ture, which creates a new dimer–dimer interface with
sequence-specific RNA binding properties (Gomis-Ru¨th et
al., 2003) resulting in octamers (Fig. 6c).
There is some evidence that the different oligomeric
forms may all have a role during the virus life cycle. Stable
dimeric VP40 has been found in Ebola virus particles (Go-
mis-Ru¨th et al., 2003) and SDS-resistant full-length VP40
octamers are found in Ebola-virus-infected cells but not in
virus particles (Gomis-Ru¨th et al., 2003). In vitro, EBO
VP40 forms also hexameric rings that seem to be stabilized
by nucleic acids. Finally, MBV VP40 also forms rings,
which are devoid of nucleic acid and assemble into stacks
with a spacing, similar to that found underneath the MBV
particle membrane. However, we cannot exclude that EBO
VP40 dimers associate or polymerize differently in order to
form virus particles although the data on MBV VP40 sug-
gest the potential presence of rings underneath the viral
membrane, which might represent more stable hexamers in
the absence of nucleic acids.
Materials and methods
Expression constructs
The generation of the expression construct for EBOV
VP40(31–212) (Zaire strain; GenBank accession number:
Fig. 6. Models of hexameric and octameric VP40. (a) Our data suggest that the
building block of each oligomer is a dimeric form of the N-terminal domain
(shown in the same gray level), which can form upon displacement of the
C-terminal domain. (b) In the hexamer conformation, the N-terminus com-
prising residues 1 to 69 is most likely intact (indicated by a black rectangle)
and involved in the dimer–dimer interface formation. (c) In the octameric
structure, the same N-terminal region is completely disordered (absent in the
drawing) and thus creates a different dimer–dimer interface, which is then
stabilized by the specific binding of sequence specific RNA (indicated as
triangles) (Gomis-Ru¨th et al., 2003). In both cases, the C-terminal domains are
flexibly linked to the N-terminus (indicated for one dimer, C).
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AY058896) has been described previously (Ruigrok et al.,
2000). EBOV VP40(1–212) was cloned into the NheI and
HindIII sites of pET21d (Novagen) for expression with a
C-terminal His-tag using standard PCR techniques. MBV
VP40 constructs were amplified by PCR from a full-length
cDNA (Popp strain; GenBank accession number: Z29337).
A construct corresponding to MBV VP40(1–186) was
cloned into the pMALc2g vector (New England Biolabs)
using the EcoRI and PstI sites. The correctness of the
sequence of each construct was verified by DNA sequenc-
ing.
Protein purification
All EBOV and MBV VP40 constructs were expressed in
E. coli strain BL21 (DE3) pUBS (Brinkmann, Mattes, and
Buckel, 1989). EBV VP40(31-212) was expressed and pu-
rified as described previously (Ruigrok et al., 2000).
Expression of EBOV VP40(1–212) was induced with 1
mM isopropyl--D-thiogalactopyranoside (IPTG) for 3 h at
37°C. Cells were lysed by sonication in a buffer containing
50 mM Bicine (pH 9.3) and 100 mM NaCl. The cleared
supernatant was subsequently loaded on a preequilibrated
Ni-affinity Sepharose column (Amersham Biosciences), and
after extensive washing with the loading buffer, the protein
was eluted in a buffer containing 50 mM Imidazole. EBOV
VP40(1-212) was further purified by size exclusion chro-
matography on a Superdex 200 column preequilibrated in
20 mM Bicine (pH 9.3) and 100 mM NaCl. Treatment with
either high NaCl concentrations and/or DNAse I and
RNAse were performed at room temperature to remove
nucleic acids.
MBV VP40(1–186) was expressed as a maltose-binding
fusion protein. Expression was induced with 1 mM IPTG
for 3 h at 37°C, and the cells were lysed by sonication in a
buffer containing 50 mM Tris–HCl (pH 8.8), 100 mM NaCl,
and 10 mM dithiothreitol (DTT). The cleared supernatant
was loaded on a preequilibrated amylose column and, after
washing with the lysis buffer, the protein was eluted with
loading buffer containing 10 mM Maltose. The MBP moi-
ety was removed by overnight digestion with a 1:50 (w/w)
ratio of Genase (New England Biolabs) at room tempera-
ture. MBV VP40(1–186) was further purified by size ex-
clusion chromatography on a Superdex 200 column pre-
equilibrated in 20 mM Bicine (pH 9.3), 100 mM NaCl, and
10 mM DTT.
Purification of VP40(31–212) under denaturing conditions
and refolding in vitro
Purified EBOV VP40(31–212) (Ruigrok et al., 2000)
was precipitated with 25% (v/v) of a 50% ammoniumsulfate
solution (w/v). The pellet was then resuspended in a buffer
containing 8 M guanidinium, 50 mM MES (morpholino
ethan sulfonic acid; pH 6.0). The buffer was subsequently
exchanged to 8 M urea, 50 mM Tris (pH 8.8) by dialysis and
the denatured protein was then separated by ion-exchange
chromatography on a Q-Sepharose resin (Amersham Bio-
sciences) preequilibrated in 8 M urea and 50 mM Tris (pH
8.8). The protein was then eluted by applying a NaCl gra-
dient in the loading buffer and subsequently precipitated
with 20% (v/v) of a 50% ammoniumsulfate solution. The
pellet was resuspended in a buffer containing 8 M urea, 100
mM NaCl, and 50 mM MES (pH 6.0) and further separated
by gel filtration chromatography (Superdex 200; Amersham
Biosciences), which resulted in a void volume peak and a
peak at 10.5 ml. VP40(31–212) from the 10.5-ml peak (OD
280/260 ratio  1.5) was then used in the refolding exper-
iment. Refolding was performed at room temperature by
slowly diluting denatured VP40(31–212) into a buffer con-
taining 50 mM Tris (pH 8.8) and 100 mM NaCl to a final
protein concentration of 2 M. Refolded VP40(31–212)
was then concentrated and separated by size exclusion chro-
matography on a Superdex 200 column preequilibrated in
50 mM Na–Hepes (pH 8.5) and 100 mM NaCl.
Conversion of dimers into octamers
Dimeric VP40(31–212) was incubated with E. coli nu-
cleic acids (30 g/ml) at a 1:10 (w/w) ratio for 1 h and
subsequently used for chemical cross-linking with 10 mM
ethyleneglycol bis(-succinimidylsuccinate) EGS (Pierce).
To show its SDS resistance the protein was loaded onto
SDS–PAGE in regular SDS loading buffer without prior
boiling of the sample.
Chemical cross-linking
EBOV VP40 samples were dialyzed against 50 mM
Hepes (pH 8.9) and 100 mM NaCl prior to cross-linking
with ethyleneglycol bis(-succinimidylsuccinate) (EGS)
(Pierce) at the indicated concentration. Cross-linking was
performed for 20 min at room temperature and reactions
were quenched with 50 mM Tris (pH 8.8). The cross-linked
samples were then separated on SDS–PAGE.
SDS resistance
To test VP40’s resistance to SDS, samples were mixed
with standard reducing SDS loading buffer and were not
boiled prior to their separation on SDS–PAGE (5–12%
gradient gels). Gels were stained with Coomassie blue.
Electron microscopy
Protein at a concentration of 0.1 mg/ml was adsorbed
to the clean side of a carbon film on mica, i.e., at the
carbon–mica interface. The carbon was then floated onto a
solution of 1% sodium silicotungstate. A grid was placed on
top of the carbon film, which was subsequently air-dried.
The samples were photographed in a JEOL 1200 EXII
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electron microscope under low-dose conditions at a nominal
magnification of 40,000.
Symmetry analysis and single-particle reconstruction
The quality of the micrographs used for image analysis
was first checked on an optical bench before scanning with
a Zeiss scanner (Photoscan TD) (pixel size of 14 m; 3.5 Å
on the sample level). The single images (side and top views)
were initially selected interactively with Ximdisp (Crowther
et al., 1996) and then processed with SPIDER (Frank et al.,
1996).
Five hundred top views were selected for symmetry
analysis from negatively stained images obtained from the
11.4-ml peak fraction (see Fig. 2a). The images were band-
pass-filtered between 25 and 200 Å without CTF correction.
Of the 500 we selected one particle, which was centered,
upon which three-, four-, or fivefold symmetry was im-
posed. The 500 particles were aligned against these three
templates (three-, four-, or fivefold symmetry rings). We
then calculated class averages and matched their symmetry
according to the image template. The class averages were
subsequently used as new templates, and this cycle was
repeated 20 times. At the end about 10% (58) of the parti-
cles lined up with the fivefold template (those were consid-
ered to be distorted rings or tilted top views). Of the 442
remaining views, 155 (35%) aligned with the threefold
symmetry ring and 287 (65%) with the fourfold symmetry
ring. This procedure was repeated with other initial parti-
cles, which resulted in similar distributions.
Single-particle reconstruction (Fig. 2f) was performed as
described previously (Ruigrok et al., 2000; Timmins et al.,
2003). Briefly, 440 images (95% side views) were selected
for the reconstruction. Half of them (220; only the ones with
the best cross correlation coefficient with the reprojection of
the model) were classified into 21 side-view class averages
and used for single-particle reconstruction.
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